Avance Clinical News

  1. 2024 KoNECT-MOHW-MFDS International Conference (KIC) Meet Avance in Seoul 10/17/2024

    Avance Clinical is proud to announce our attendance at the 2024 KoNECT-MOHW-MFDS International Conference (KIC) in Seoul, South Korea, October 29 – 31, 2024. As part of our commitment to expanding our global presence and strengthening our capabilities in the Asia-Pacific region, CEO Yvonne Lungershausen and Asia Regional Director Jessica Han will be attending the conference, meeting with biotech clients and partners to discuss opportunities in early and late-phase clinical trials.

  2. Avance Clinical Welcomes Kelly Yang As Associate Director, Operations Taiwan 10/17/2024

    Avance Clinical, a leading global contract research organization (CRO) specializing in advanced clinical research solutions for biotechs, is excited to announce the appointment of Kelly Yang as Associate Director, Operations Taiwan. Kelly brings over 15 years of experience in the pharmaceutical and clinical research industries, making her a valuable addition to Avance Clinical’s growing team.

  3. Avance Clinical GlobalReady Site Partnership Network Expands Rapidly To 2,000 Site Members 9/4/2024
  4. Avance Clinical Wins 2024 Frost & Sullivan Award For Global Biotech CRO Excellence 8/28/2024

    Avance Clinical, a leading global CRO specializing in clinical trials for the biotech sector, has won the prestigious 2024 Frost & Sullivan Best Practices Customer Value Leadership Award for Global Biotech CRO Excellence.

  5. Avance Clinical Appoints Asia Regional Director As Part Of Global Expansion Program 7/22/2024

    Avance Clinical, the award-winning CRO for biotechs, is proud to announce the appointment of Jessica Han as Director, Asian Operations based out of the Avance Clinical’s Seoul, Korea office.

  6. Avance Clinical Welcomes Joe Taouk As Vice President, Global Project Delivery 6/28/2024

    Avance Clinical, the largest specialist Australian and US CRO, is thrilled to announce the appointment of Joe Taouk as Vice President, Global Project Delivery.

  7. New Research Launched At BIO24 Finds CROs With In-House Regulatory Affairs Deliver 30% Savings, Halve Timelines And Cut Risk For Biotechs 6/4/2024

    Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, is sharing new data at BIO 2024 from Frost & Sullivan research showing biotechs save more than 30% in costs and halve start-up times with CROs that have in-house scientific and regulatory affairs.

  8. Avance Clinical Expands Specialist CNS, Cardiometabolic, And Rare Diseases CRO Services In Europe With Julius Clinical 5/28/2024

    Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS, cardiometabolic, and rare diseases specialist CRO with extensive site relationships in the region.

  9. Avance Clinical Expands Further Into APAC With New Clinical Operations In South Korea – Seoul Office Announced At BIO Korea 2024 5/9/2024

    Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, will attend BIO Korea (May 8-10, 2024) and formally open new clinical operations in Seoul, South Korea.

  10. Avance Clinical Welcomes Alex Kavros As Executive Vice President Of Scientific & Regulatory Affairs 5/6/2024

    Avance Clinical, a leading Contract Research Organization (CRO) renowned for its innovative solutions in the biotech industry, is excited to announce the appointment of Dr Alex Kavros as the new Executive Vice President of Global Scientific & Regulatory Affairs.